M Jessup, B Greenberg, D Mancini, T Cappola… - Circulation, 2011 - Am Heart Assoc Mariell Jessup, MD; Barry Greenberg, MD; Donna Mancini, MD; Thomas Cappola, MD; Daniel F. Pauly, MD, PhD; Brian Jaski, MD; Alex Yaroshinsky, PhD; Krisztina M. Zsebo, PhD; Howard Dittrich, MD; Roger J. Hajjar, MD; on behalf of the Calcium Upregulation by Percutaneous ... Cited by 4 - Related articles - All 3 versions
Y Ito, H Murano, N Hamasaki, K Fukushima… - International journal of …, 2011 - Elsevier Two-layered dissolving microneedles of which acral portion contained leuprolide acetate (LA) as solid dispersion were prepared with sodium chondroitin sulfate as the base and the systemic absorption efficiency of LA was studied in rats after administration to their abdominal skin. ... All 3 versions
S Zhang, G Qin, Y Wu, Y Gao, Y Qiu, F Li… - Pharmaceutical research, 2011 - Springer ... ABSTRACT Purpose In vitro and in vivo permeation studies were conducted to evaluate the characteristic of percutaneousadministration of high hydrophilic drug L-carnitine (LC) by Functional MicroArray (FMA) painless intradermal delivery system. ... Related articles - All 4 versions
F Caillet-bois, I Rault… - US Patent …, 2011 - freepatentsonline.com 1. A composition intended for percutaneous administration of a physiologically active compound, which consists essentially of (a) 0.1-20% (w/v) of at least one physiologically active compound, (b) 0.5-30% (w/v) of a hydrophobic polymer selected from the group ... Cached